Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common form of human lymphoma. While a number of structural alterations have been associated with the pathogenesis of this malignancy, the full spectrum of genetic lesions that are present in the DLBCL genome, and therefore the identity of dysregulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasqualucci, Laura, Trifonov, Vladimir, Fabbri, Giulia, Ma, Jing, Rossi, Davide, Chiarenza, Annalisa, Wells, Victoria A., Grunn, Adina, Messina, Monica, Elliot, Oliver, Chan, Joseph, Bhagat, Govind, Chadburn, Amy, Gaidano, Gianluca, Mullighan, Charles G., Rabadan, Raul, Dalla-Favera, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297422/
https://www.ncbi.nlm.nih.gov/pubmed/21804550
http://dx.doi.org/10.1038/ng.892
Descripción
Sumario:Diffuse large B-cell lymphoma (DLBCL) is the most common form of human lymphoma. While a number of structural alterations have been associated with the pathogenesis of this malignancy, the full spectrum of genetic lesions that are present in the DLBCL genome, and therefore the identity of dysregulated cellular pathways, remains unknown. By combining next-generation sequencing and copy number analysis, we show that the DLBCL coding genome contains on average more than 30 clonally represented gene alterations/case. This analysis also revealed mutations in genes not previously implicated in DLBCL pathogenesis, including those regulating chromatin methylation (MLL2, 24% of cases) and immune recognition by T cells. These results provide initial data on the complexity of the DLBCL coding genome and identify novel dysregulated pathways underlying its pathogenesis.

Ejemplares similares